FindTrial
Sign In

RSV Burden estimation in the population

Respiratory syncytial virus (RSV): Burden estimation and the development of a monoclonal antibody-based point of care diagnostic - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/081452
Enrollment
600
Registered
2025-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with ILI and SARI symptoms admitted to KMC Manipal

Exclusion criteria

Exclusion criteria: Patients with chronic illness

Design outcomes

Primary

MeasureTime frame
Understanding the burden of RSV in the communityTimepoint: Baseline—

Secondary

MeasureTime frame
Predict the Seasonality of RSVTimepoint: 36 Months—

Countries

India

Contacts

Public ContactAnup Jayaram

Manipal Institute of Virology, Manipal Academy of Higher Education

anup.jayaram@manipal.edu08202922663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026